Opthea OPT Stock
Opthea Price Chart
Opthea OPT Financial and Trading Overview
| Opthea stock price | 3.41 USD |
| Previous Close | 3.12 USD |
| Open | 3.06 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 3.06 - 3.18 USD |
| 52 Week Range | 3.06 - 7.99 USD |
| Volume | 4.51K USD |
| Avg. Volume | 8.45K USD |
| Market Cap | 183.85M USD |
| Beta (5Y Monthly) | 0.314559 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.25 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 19.27 USD |
OPT Valuation Measures
| Enterprise Value | 130.27M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 757.5066 |
| Price/Book (mrq) | 3.2541323 |
| Enterprise Value/Revenue | 536.739 |
| Enterprise Value/EBITDA | -0.958 |
Trading Information
Opthea Stock Price History
| Beta (5Y Monthly) | 0.314559 |
| 52-Week Change | -42.72% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.99 USD |
| 52 Week Low | 3.06 USD |
| 50-Day Moving Average | 3.53 USD |
| 200-Day Moving Average | 4.69 USD |
OPT Share Statistics
| Avg. Volume (3 month) | 8.45K USD |
| Avg. Daily Volume (10-Days) | 2.75K USD |
| Shares Outstanding | 58.36M |
| Float | 38.35M |
| Short Ratio | 10.43 |
| % Held by Insiders | 0% |
| % Held by Institutions | 18.46% |
| Shares Short | 77.21K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.13% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -56036.65% |
| Gross Margin | 15.42% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -64.58% |
| Return on Equity (ttm) | -168.68% |
Income Statement
| Revenue (ttm) | 242.7K USD |
| Revenue Per Share (ttm) | 0.008 USD |
| Quarterly Revenue Growth (yoy) | 28.49% |
| Gross Profit (ttm) | 38.5K USD |
| EBITDA | -135992272 USD |
| Net Income Avi to Common (ttm) | -132203624 USD |
| Diluted EPS (ttm) | -2.52 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 141.77M USD |
| Total Cash Per Share (mrq) | 2.43 USD |
| Total Debt (mrq) | 88.19M USD |
| Total Debt/Equity (mrq) | 156.18 USD |
| Current Ratio (mrq) | 16.322 |
| Book Value Per Share (mrq) | 0.968 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -111867136 USD |
| Levered Free Cash Flow (ttm) | -72191792 USD |
Profile of Opthea
| Country | United States |
| State | VIC |
| City | South Yarra |
| Address | 650 Chapel Street |
| ZIP | 3141 |
| Phone | 61 3 9826 0399 |
| Website | https://opthea.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema (DME), as well as a first in class VEGF-C/D inhibitors for treatment with VEGF-A inhibitors to treat wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.
Q&A For Opthea Stock
What is a current OPT stock price?
Opthea OPT stock price today per share is 3.41 USD.
How to purchase Opthea stock?
You can buy OPT shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Opthea?
The stock symbol or ticker of Opthea is OPT.
Which industry does the Opthea company belong to?
The Opthea industry is Biotechnology.
How many shares does Opthea have in circulation?
The max supply of Opthea shares is 153.91M.
What is Opthea Price to Earnings Ratio (PE Ratio)?
Opthea PE Ratio is now.
What was Opthea earnings per share over the trailing 12 months (TTM)?
Opthea EPS is -2.25 USD over the trailing 12 months.
Which sector does the Opthea company belong to?
The Opthea sector is Healthcare.
Opthea OPT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Global Select Market Com NQGS | 8504.39 USD — |
+1.34
|
— — | 8367.19 USD — | 8515.13 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}